Lymphadenopathy and antibodies to HTLV-III in homosexual men. Clinical, laboratory and epidemiological features. 1985

U Bienzle, and I Guggenmoos-Holzmann, and K Zwingenberger, and R Thommsen, and K Ritter, and A Uy, and H Bayer, and J Schneider, and G Hunsmann, and C H Coester

The study provides information on the epidemiology of HTLV-III infection and the lymphadenopathy syndrome (LAP) in 374 German homosexual men. Sexual contacts in the USA and rectal enemas before receptive anal intercourse are the main risk factors associated with virus transmission. HTLV-III seropositivity is significantly correlated with LAP. Prominent clinical signs are infrequent. Immunological and haematological abnormalities are prevalent, and the retrovirus infection is frequently associated with serological markers of other viruses (hepatitis B, herpes group viruses). Lymphadenopathy as a manifestation of HTLV-III infection is discussed within the context of AIDS-related disorders.

UI MeSH Term Description Entries
D008019 Life Style Typical way of life or manner of living characteristic of an individual or group. (From APA, Thesaurus of Psychological Index Terms, 8th ed) Lifestyle Factors,Life Style Induced Illness,Lifestyle,Factor, Lifestyle,Life Styles,Lifestyle Factor,Lifestyles
D008206 Lymphatic Diseases Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS. Lymphatism,Status Lymphaticus,Disease, Lymphatic,Diseases, Lymphatic,Lymphatic Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006716 Homosexuality The sexual attraction or relationship between members of the same SEX. Homosexuality, Ego-Dystonic,Ego-Dystonic Homosexuality,Homosexuality, Ego Dystonic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

U Bienzle, and I Guggenmoos-Holzmann, and K Zwingenberger, and R Thommsen, and K Ritter, and A Uy, and H Bayer, and J Schneider, and G Hunsmann, and C H Coester
June 1985, The New England journal of medicine,
U Bienzle, and I Guggenmoos-Holzmann, and K Zwingenberger, and R Thommsen, and K Ritter, and A Uy, and H Bayer, and J Schneider, and G Hunsmann, and C H Coester
January 1986, Clinical and investigative medicine. Medecine clinique et experimentale,
U Bienzle, and I Guggenmoos-Holzmann, and K Zwingenberger, and R Thommsen, and K Ritter, and A Uy, and H Bayer, and J Schneider, and G Hunsmann, and C H Coester
March 1985, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
U Bienzle, and I Guggenmoos-Holzmann, and K Zwingenberger, and R Thommsen, and K Ritter, and A Uy, and H Bayer, and J Schneider, and G Hunsmann, and C H Coester
April 1985, Clinical and experimental immunology,
U Bienzle, and I Guggenmoos-Holzmann, and K Zwingenberger, and R Thommsen, and K Ritter, and A Uy, and H Bayer, and J Schneider, and G Hunsmann, and C H Coester
March 1986, The British journal of surgery,
U Bienzle, and I Guggenmoos-Holzmann, and K Zwingenberger, and R Thommsen, and K Ritter, and A Uy, and H Bayer, and J Schneider, and G Hunsmann, and C H Coester
September 1985, The Medical journal of Australia,
U Bienzle, and I Guggenmoos-Holzmann, and K Zwingenberger, and R Thommsen, and K Ritter, and A Uy, and H Bayer, and J Schneider, and G Hunsmann, and C H Coester
March 1986, Cellular immunology,
U Bienzle, and I Guggenmoos-Holzmann, and K Zwingenberger, and R Thommsen, and K Ritter, and A Uy, and H Bayer, and J Schneider, and G Hunsmann, and C H Coester
September 1985, Cancer research,
U Bienzle, and I Guggenmoos-Holzmann, and K Zwingenberger, and R Thommsen, and K Ritter, and A Uy, and H Bayer, and J Schneider, and G Hunsmann, and C H Coester
December 1986, Genitourinary medicine,
U Bienzle, and I Guggenmoos-Holzmann, and K Zwingenberger, and R Thommsen, and K Ritter, and A Uy, and H Bayer, and J Schneider, and G Hunsmann, and C H Coester
April 1986, The American journal of pathology,
Copied contents to your clipboard!